Bronchoscopy examination
Conditions
Interventions
Group C:Using Cyclopol asa sedative for general anesthesia
Group R:Using Remazolam as a sedative for general anesthesia
Group R:Using etomidate as a sedative for general anesthesia
Group RC:Using Remazolam Combined with Cyclopol as a sedative for general anesthesia
Group RE:Using Remazolam Combined with Etomidate as a sedative for general anesthesia
Sponsors
People's Hospital of Ningxia Hui Autonomous Region
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: ? Patients who undergo scheduled bronchoscopy surgery; ? Age 18-80 years ; ? BMI 18.5-25 kg/m^2; ? ASA I-III; ? Patients or their families signed an informed consent form for anesthesia before surgery and voluntarily participated in this study.
Exclusion criteria
Exclusion criteria: ? Inability or allergy to the investigational drug; ? Individuals with uncontrolled or malignant hypertension, hypotension (SAP5mm.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The incidence of hypotension ;Patient's postoperative cough score;Postoperative recovery time; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative nausea and vomiting;The incidence of low blood oxygen saturation;Directional force recovery time;The occurrence of intraoperative dreams;Number of adverse events; | — |
Countries
China
Contacts
Public ContactWang Ting
People's Hospital of Ningxia Hui Autonomous Region
Outcome results
None listed